Amicus Therapeutics Valuation
| FOLD Stock | USD 10.71 0.11 1.02% |
At this time, the firm appears to be undervalued. Amicus Therapeutics shows a prevailing Real Value of $13.46 per share. The current price of the firm is $10.71. Our model approximates the value of Amicus Therapeutics from analyzing the firm fundamentals such as Profit Margin of (0.38) %, current valuation of 3.27 B, and Return On Equity of -1.07 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Amicus Therapeutics' valuation include:
Price Book 19.6954 | Enterprise Value 3.3 B | Enterprise Value Ebitda (35.99) | Price Sales 7.8994 | Forward PE 72.9927 |
Undervalued
Today
Please note that Amicus Therapeutics' price fluctuation is not too volatile at this time. Calculation of the real value of Amicus Therapeutics is based on 3 months time horizon. Increasing Amicus Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Amicus Therapeutics is useful when determining the fair value of the Amicus stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Amicus Therapeutics. Since Amicus Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amicus Stock. However, Amicus Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.71 | Real 13.46 | Target 17.33 | Hype 10.67 | Naive 9.96 |
The real value of Amicus Stock, also known as its intrinsic value, is the underlying worth of Amicus Therapeutics Company, which is reflected in its stock price. It is based on Amicus Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Amicus Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amicus Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amicus Therapeutics helps investors to forecast how Amicus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amicus Therapeutics more accurately as focusing exclusively on Amicus Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Amicus Therapeutics' intrinsic value based on its ongoing forecasts of Amicus Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Amicus Therapeutics' closest peers. When choosing an evaluation method for Amicus Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Amicus Therapeutics Investments |
|
Amicus Valuation Trend
Knowing Amicus Therapeutics' actual value is paramount for traders to make sound investment determinations. Amicus Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Amicus Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Amicus Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Amicus Market Cap
Amicus Therapeutics is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 4.04 Billion. Amicus Therapeutics totals roughly 3.16 Billion in market capitalization claiming about 78% of equities under Health Care industry.Amicus Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Amicus Therapeutics's current stock value. Our valuation model uses many indicators to compare Amicus Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amicus Therapeutics competition to find correlations between indicators driving Amicus Therapeutics's intrinsic value. More Info.Amicus Therapeutics is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies . The current year's Price To Book Ratio is expected to grow to 27.46. Comparative valuation analysis is a catch-all model that can be used if you cannot value Amicus Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amicus Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amicus Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amicus Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amicus Therapeutics and how it compares across the competition.
About Amicus Therapeutics Valuation
The stock valuation mechanism determines the current worth of Amicus Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Amicus Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amicus Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Amicus Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Amicus Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amicus Therapeutics. We calculate exposure to Amicus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amicus Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 354.2 M | 371.9 M | |
| Pretax Profit Margin | (0.38) | (0.39) | |
| Operating Profit Margin | (0.18) | (0.19) | |
| Net Loss | (0.38) | (0.40) | |
| Gross Profit Margin | 0.89 | 0.70 |
8 Steps to conduct Amicus Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amicus Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amicus Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amicus Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amicus Therapeutics' revenue streams: Identify Amicus Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amicus Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amicus Therapeutics' growth potential: Evaluate Amicus Therapeutics' management, business model, and growth potential.
- Determine Amicus Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amicus Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Amicus Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Amicus Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 295.2 M | |
| Forward Price Earnings | 72.9927 |
Amicus Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Amicus Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Amicus we look at many different elements of the entity such as Amicus's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Amicus Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Amicus Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Amicus Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Amicus Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Amicus Therapeutics' worth.When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Amicus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share 1.353 | Quarterly Revenue Growth 0.306 | Return On Assets (0.06) | Return On Equity (1.07) |
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.